Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

232 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-31

Study Completion Date

2018-11-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MTN-041 study is a multi-site exploratory study using focus group discussions (FGDs) and in-depth interviews (IDIs) to identify individual, interpersonal, social and cultural factors that may affect potential uptake of two safe and effective HIV prevention products, the monthly dapivirine (DPV) vaginal ring (VR) and daily oral pre-exposure prophylaxis (PrEP), by pregnant and breastfeeding women in Africa.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy

NCT03965923

HIV Infections

COMPLETED PHASE3

Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

NCT03902418

HIV-I Infection

COMPLETED

UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study

NCT06158126

Pre-exposure Prophylaxis HIV Prevention Pregnancy Related

RECRUITING PHASE4

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

NCT00028145

HIV Infections Pregnancy Complications, Infectious

COMPLETED

Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs

NCT04140266

HIV Infections

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

MTN-041 is an exploratory study primarily designed to identify individual, interpersonal, social and cultural factors that may affect potential uptake of two safe and effective HIV prevention products, the monthly DPV VR and daily oral PrEP, in a vulnerable yet seldom-studied population, pregnant and breastfeeding women. MTN-041 will utilize FGDs and IDIs to elicit community and health professional perceptions about vaginal practices, sexual activity, use of medicines, and HIV risk during pregnancy or breastfeeding, including how these perceptions may affect pregnant and breastfeeding women's acceptability of using intravaginal products and oral medications like the DPV VR and Truvada oral tablet.

The MTN-041 study population will consist of HIV-uninfected women 18-40 years old who are currently or were recently (within two years) pregnant or breastfeeding, men aged 18 years or older whose partners are currently or were recently (within two years) pregnant or breastfeeding, grandmothers whose daughters or daughters-in-law are currently or were recently (within two years) pregnant or breastfeeding, and key informants (KIs), which include: health care professionals (HCPs), traditional birth attendants (TBAs), providers of family planning, antenatal, and traditional health services to women, providers of other social services to women, and community leaders.

Up to 60 men and women will be selected at each site for participation in this study, for a maximum total of 240 study participants. This includes up to 50 FGD participants (currently or recently pregnant or breastfeeding women, male partners of women who are currently or were recently pregnant or breastfeeding, and grandmothers with currently or recently pregnant or breastfeeding daughters/daughters-in-law) and up to 10 KIs selected at each site, for a maximum total of 200 FGD participants and 40 KIs enrolled across all sites.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant or Breastfeeding Women

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures.

Focus Group Discussion (FGD)

Intervention Type BEHAVIORAL

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures. In particular, the FGDs will focus on:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* Willingness to join a VR and/or oral PrEP study during pregnancy and breastfeeding

Male Partners

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures.

Focus Group Discussion (FGD)

Intervention Type BEHAVIORAL

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures. In particular, the FGDs will focus on:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* Willingness to join a VR and/or oral PrEP study during pregnancy and breastfeeding

Grandmothers

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures.

Focus Group Discussion (FGD)

Intervention Type BEHAVIORAL

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures. In particular, the FGDs will focus on:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* Willingness to join a VR and/or oral PrEP study during pregnancy and breastfeeding

Key Informants

No actual intervention is planned. A single in-depth interview (IDI) will be conducted to assess study outcome measures.

In-depth Interview (IDI)

Intervention Type BEHAVIORAL

No actual intervention is planned. A single in-depth interview (IDI) will be conducted to assess study outcome measures, focusing on the following topics:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* How others in their professional and social networks and communities would view the VR and/or oral PrEP use by pregnant and breastfeeding women

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focus Group Discussion (FGD)

No actual intervention is planned. A single focus group discussion (FGD) with community members in the same group assignment will be conducted to assess study outcome measures. In particular, the FGDs will focus on:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* Willingness to join a VR and/or oral PrEP study during pregnancy and breastfeeding

Intervention Type BEHAVIORAL

In-depth Interview (IDI)

No actual intervention is planned. A single in-depth interview (IDI) will be conducted to assess study outcome measures, focusing on the following topics:

* Perceptions of taboos and acceptable and/or typical practices during pregnancy, childbirth and breastfeeding
* Perceptions of HIV risk during pregnancy and breastfeeding
* Perceived role of male partners during pregnancy and breastfeeding
* Main challenge(s) perceived with VR and oral PrEP use during pregnancy and breastfeeding
* Main factor(s) perceived to facilitate VR and oral PrEP use during pregnancy and breastfeeding
* How others in their professional and social networks and communities would view the VR and/or oral PrEP use by pregnant and breastfeeding women

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Able and willing to provide written informed consent in one of the study languages.
2. Able and willing to complete the required study procedures.

For currently or recently pregnant or breastfeeding women:
3. Between the ages of 18 to 40 years old (inclusive) at Enrolment, verified per site standard operating procedures (SOPs).
4. Currently or recently (within two years) pregnant or breastfeeding (by self-report).

For male partners:
5. Aged 18 years or older at Enrolment, verified per site SOPs.
6. Identifies as a primary sexual partner of a woman who is currently or was recently (within two years) pregnant or breastfeeding.

For grandmothers:
7. Aged 18 years or older at Enrolment, verified per site SOPs.
8. Identifies as the maternal or paternal grandmother of a daughter or daughter-in-law who is currently or was recently (within two years) pregnant or breastfeeding.

Note: The term "daughter-in-law" includes women who are/were not married to their male partner during or after pregnancy.

For service provider KIs:
9. Aged 18 years or older at Enrolment, verified per site SOPs.
10. Currently working as a clinician (e.g., obstetrician, nurse, pharmacist, etc.), traditional care provider (e.g., TBA, healer, midwife, etc.), social service provider (e.g., social worker, family planning counselor, etc.) or community health worker in one of the study countries, verified per site SOPs.
11. Experienced in providing services to pregnant and/or breastfeeding women.

For community leader KIs:
12. Aged 18 years or older at Enrolment, verified per site SOPs.
13. Currently acting in a community leadership role (e.g., local chief, religious leader, etc.).

Exclusion Criteria

1. Has any condition that, in the opinion of the Investigator of Record (IoR)/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
2. For currently or recently pregnant or breastfeeding women: known HIV-positive status, verified per recent health record (e.g., health passport, ante-natal book, HIV test card, or similar document) or by self-report if health record(s) not available.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No